pravastatin has been researched along with Carcinoma, Colloid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, ML; Desai, P; Howard, BV; Manson, JE; Martin, LW; Ray, RM; Rohan, T; Safford, M; Simon, MS; Wallace, R; Wu, C | 1 |
Auboire, L; Landy, S; Le Hello, C; Maïza, D; Perrot, JY | 1 |
1 review(s) available for pravastatin and Carcinoma, Colloid
Article | Year |
---|---|
[A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
Topics: Adenocarcinoma, Mucinous; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Estrogens; Female; Galantamine; Humans; Mammography; Mastectomy; Neoplasms, Hormone-Dependent; Nitriles; Paraneoplastic Syndromes; Pravastatin; Progesterone; Radiotherapy, Adjuvant; Raynaud Disease; Seasons; Triazoles; Verapamil | 2010 |
1 other study(ies) available for pravastatin and Carcinoma, Colloid
Article | Year |
---|---|
An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Carcinoma, Endometrioid; Carcinosarcoma; Endometrial Neoplasms; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Postmenopause; Pravastatin; Proportional Hazards Models; Risk Factors; United States; Women's Health | 2018 |